Conclusion
The incidence of HCM is estimated at 0.2%, while Marfan syndrome occurs much less frequently. How is the physician to find the rare disease that can kill a patient in his adolescence? As in the case of other uncommon diseases, clinical suspicion and careful history and physical examination are of primary importance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Maron BJ, et al. Sudden death in young competitive athletes: clinical, demographic and pathologic profiles.JAMA. 1996;276:199–204.
Maron BJ, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study.Circulation. 1995;92:785–789.
Maron BJ, et al. Cardiovascular preparaticipation screening of competitive athletes.Circulation. 1996;94:850–856.
Vincent GM. Sudden death in a young athlete.Physician Sportsmed. 1998;26:59–62.
Smith J, et al. The preparticipation physical examination: Mayo Clinic experience with 2,739 examinations.Mayo Clin Proc. 1998;73:419–429.
Corrado D, et al. Screening for hypertrophic cardiomyopathy in young athletes.N Engl J Med. 1998;339:364–369.
Author information
Authors and Affiliations
About this article
Cite this article
Weiner, H.R. Preventing sudden death in student athletes. Compr Ther 25, 151–154 (1999). https://doi.org/10.1007/BF02889611
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02889611